News
The United States Food and Drug Administration (FDA) has approved a twice-a-year injectable drug to be used for HIV ...
Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback